Estar Medical is a world leader in Platelet-Rich Plasma (PRP) and autologous cell therapy technologies and is proud to be at the forefront of regenerative medicine companies with our unique patented FDA and CE technology that delivers progressive non-surgical healing treatment in multiple medical applications such as: Aesthetics, Orthopedics, Wound Management, Dental, Cardiology, Ophthalmology, Veterinary and more.
Complementary Products
News & Events
May 21, 2019
European Patent Office revoked Regenlab PRP patent
Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent…
Jun 6, 2019
TOBI 10th Annual PRP & Regenerative Medicine Symposium, Workshops & Cadaver Labs
Estar Medical is delighted to take part in the TOBI congress - a major yearly…
Jun 7, 2019
FACE – Facial Aesthetic Conference & Exhibition, London, UK
Estar Medical is delighted to take part in the FACE conference and exhibition. UK's premier…
Jan 2, 2019
UK High Court Refuses to Grant Regen Lab Permission to Appeal the PRP Patent Revocation Judgement
The UK Court refused to grant Regenlab permission to appeal the finding that its European…
Apr 4, 2019
AMWC 17th Aesthetic & Anti-Aging Medicine World Congress
Estar medical is delighted to take part in the AMWC congress that has targeted effective…
Jan 31, 2019
IMCAS World Congress 2019 31 January – 2 February 2019 PARIS
Estar medical is delighted to take part in the IMCAS congress that has targeted effective…